Search

When Yehuda’s leg pain was diagnosed as Ewing sarcoma, his family brought him to Memorial Sloan Kettering for treatment, which included a 14-hour surgery.

… Hear from Our Child & Teen Patients Yehuda’s Story By Memorial Sloan Kettering Editorial Staff When six-year-old Yehuda developed sudden, unexplainable leg pain, his parents were stunned when he was diagnosed with Ewing sarcoma , a rare cancer that involves the bone and soft tissue. Because the tumor

… Job Title Postdoctoral Research Fellow Current Position: Senior Research Scientist in the Molecular Cytology Core Facility, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York Degree PhD Start Year 2010 End Year 2012 Email [email protected] Publications Perea-Gomez A, Cases O, Lelièvre

… May 7, 2003 Nature’s Youth, LLC, of Centerville, Massachusettes has completed a voluntary destruction of approximately $515,000 worth of its misbranded product, “Nature’s Youth hGH”. The manufacturers claimed the supplement would, “improve physical performance, speed recovery from training, increase

Si es paciente o familiar de una persona que recibe tratamiento en MSK, reúne los requisitos para postularse al Consejo Asesor de Calidad para Pacientes y Familias.

… Le agradecemos su interés por formar parte del Consejo Asesor de Calidad para Pacientes y Familias (PFACQ) de MSK.  Nuestra misión es integrar la perspectiva del paciente y la de la familia en cada aspecto de las acciones de MSK para prevenir, diagnosticar, tratar y curar el cáncer. Este programa fortalece

A new study sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing. According to the study's findings, researchers identified the genetic pathway used to maintain a cell's quiescence, a state that allows bone marrow cells to escape the lethal effects of standard cancer treatments.

… Friday, January 9, 2009 A new study sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing. According to the study’s findings, researchers identified the genetic

… Job Title Postdoctoral Researcher Education Dr. rer. nat., TUM School of Life Sciences, Technical University of Munich, Munich, Germany;M.Sc., Applied Mathematics, École polytechnique fédérale de Lausanne, Lausanne, Switzerland;M.Sc., Mathematics, Technical University of Munich, Munich, Germany;B.Sc.

… Job Title Administrative Assistant Email [email protected] Office Fax 212-717-3604 Office Phone 212-639-2578

Address some of the most common symptoms seen during treatment, with a variety of focused mind-body practices.

… Address some of the most common symptoms seen during treatment, with a variety of focused mind-body practices. Survivorship: Stress and Anxiety Address some of the most common symptoms seen during treatment, with a variety of focused mind-body practices. Calm Anxiety: Music Listen to this soothing melody

The combination of nivolumab (Opdivo®) and ipilimumab (Yervoy®) has shown improved progression-free survival (PFS) compared with chemotherapy as a first-line treatment for people with a high tumor mutational burden (TMB) in advanced non-small cell lung cancer (NSCLC). Data from the CheckMate -227 trial is being reported by Matthew Hellmann, MD, of Memorial Sloan Kettering Cancer Center, at the AACR Annual Meeting 2018. This research is featured in the meeting’s press program, and findings are being presented in the Clinical Trials Plenary Session, “Immunotherapy Combinations: The New Frontier in Lung Cancer.”

… Monday, April 16, 2018 The combination of nivolumab (Opdivo ® ) and ipilimumab (Yervoy ® ) has shown improved progression-free survival (PFS) compared with chemotherapy as a first-line treatment for people with a high tumor mutational burden (TMB) in advanced non-small cell lung cancer (NSCLC). Data

The Genitourinary Pathology Fellowship is a sub-specialty training program in the Department of Pathology at Memorial Sloan Kettering. The Fellowship provides extensive exposure to all aspects of genitourinary tumor pathology, including in-depth experience with tumor specimens from the kidney, urinary bladder, prostate and testis.

… The Genitourinary (GU) Pathology Fellowship is a sub-specialty training program in the Department of Pathology at Memorial Sloan Kettering Cancer Center. The Fellowship provides extensive exposure to all aspects of genitourinary tumor pathology, including in-depth experience with tumor specimens from